|Last Price||Today's Change||52-Week Range||Trading Volume|
|23.20||-0.08 (-0.33%)||21.51 - 27.52||34.6 thousand|
Market data as of 3:45PM 02/12/16. Quotes are delayed by at least 15 min.
FDA Psychopharmacologic Drug Advisory Committee Supports the Effectiveness of Brintellix® (vortioxetine) in Treating Certain Aspects of Cognitive Dysfunction in Major Depressive Disorder (MDD)
02/03/2016 8:36 PM ET
FDA Approves Takeda's Dexilant SoluTab (dexlansoprazole)
01/27/2016 12:00 PM ET